Design Corp (DSGN) Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi

Design Therapeutics (DSGN) korporativ emblemasi va logotipi

Design Therapeutics (DSGN) irsiy patologiyalarni tuzatish uchun innovatsion dori vositalarini ishlab chiqadi. Ushbu narxlar grafigi murakkab inyeksiyalar o'rniga hamyonbop planshet asosidagi terapiyalarni yaratish uchun GeneTAC texnologiyasidan foydalanadigan kompaniyaning moliyaviy natijalarini vizuallashtiradi, bunda ko'rsatkich 0.01 darajasida turibdi. Biznes patentlangan molekulyar agentlarning tijoratlashtirilishi orqali kelajakda kapital to'plashni rejalashtirmoqda. Operatsion faoliyat tadqiqotlarning US ilmiy markazlarida lokalizatsiyalanganligi sababli tashqi sanksiyalardan himoyalangan.

Design Corp (DSGN): Uzoq muddatli qarzning kapitalga nisbati 04.07.2022dan 29.10.2026gacha

Design Therapeutics kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Aksiya kursi Design Therapeutics Inc|DSGN - Maqsadli narxlar grafigi
- bozor kapitallashuvi tafsilotlari:
Bozor kapitallashuvi Design Therapeutics, Inc.|DSGN - Korxona qiymati
- emitentning balans qiymati statistikasi:
Bitta aksiya hisobiga balans qiymati Design Therapeutics|DSGN - Balans kapitallashuvi|Kapitallashuvning balans qiymatiga nisbati designtx.com|DSGN - Kompaniyaning umumiy aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning kapitalga nisbati Design Therapeutics|DSGN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga koeffitsiyenti designtx.com|DSGN - Kompaniyaning jamlangan qarzlari|Sof aktivlarga qarzlar Design Therapeutics, Inc.|DSGN - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarzdorlik Design Therapeutics|Shoshilinch likvidlik koeffitsiyenti designtx.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
DSGN - Sof daromad
Kompaniyaning jamlanma tahlili:Design Therapeutics
Design Therapeutics, Inc. original mahsuloti

Ushbu ko'rsatkich moliyalashtirish tuzilmasining barqarorligini baholash uchun bir yildan ortiq muddatga ega majburiyatlarni kapital bilan solishtirish orqali uzoq muddatli moliyaviy leveraj darajasini aniqlaydi. Uzoq muddatli kreditlarning kapitalga nisbatini tahlil qilish orqali investor Design Therapeutics (DSGN) kompaniyasining o'z ishlab chiqarish zavodlari yo'qligi va tashqi autsorsing xarajatlariga to'liq bog'liqligi sharoitida o'z ilmiy faoliyatini qo'llab-quvvatlash qobiliyatini baholashi mumkin.

Muhim raqobatchilar

Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi TEM (Tempus)|Uzoq muddatli qarzning o'z kapitaliga nisbati Qiagen Group (QGEN)|Isis Pharmaceuticals - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati RGEN (Repligen Corporation)|Uzoq muddatli qarzning kapitalga nisbati aviditybiosciences.com RNA|CRISPR Therapeutics - Uzoq muddatli qarzning kapitalga nisbati|WGS (GeneDx Holdings) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|RARE: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Beam Tx (BEAM)|Uzoq muddatli qarzning o'z kapitaliga nisbati Sarepta Therapeutics, Inc.|twistbioscience.com (TWST) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati TXG|Uzoq muddatli qarzdorlikning kapitalga nisbati Intellia Therapeutics Inc|Uzoq muddatli qarzning kapitalga nisbati STOK (Stoke)|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati BioLife|WVE - Uzoq muddatli qarzning o'z kapitaliga nisbati|MAZE (mazetx.com) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|SION (Sionna Therapeutics) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Prime Medicine Inc - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati TSHA|QURE (uniQure Pharma) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati MGTX|RGNX (regenxbio.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati SLDB (Solid Biosciences)|Ocugen Inc (OCGN) - Uzoq muddatli majburiyatlarning kapitalga nisbati|PACB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti BNTC (Benitec Corp)|RCKT: Uzoq muddatli qarzning kapitalga nisbati|4dmoleculartherapeutics.com (FDMT) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Lexeo Therapeutics Inc.|Korro Bio, Inc - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati EDIT|SLN - Uzoq muddatli majburiyatlarning kapitalga nisbati|ProQR Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati Codexis Inc CDXS|SGMO: Uzoq muddatli qarzning o'z kapitaliga nisbati|Nautilus Biotechnology - Uzoq muddatli kreditlarning kapitalga nisbati|MGX: Uzoq muddatli qarzning kapitalga nisbati|DTIL - Uzoq muddatli qarzdorlikning kapitalga nisbati|GBIO (Generation Bio Co) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati boundlessbio.com (BOLD)|Uzoq muddatli qarzning o'z kapitaliga nisbati Exicure, Inc. (XCUR)|Uzoq muddatli qarzdorlikning kapitalga nisbati imunon.com|Uzoq muddatli qarzning kapitalga nisbati PHIO (Phio Pharmaceuticals Corp.)|MBIO: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|RNAZ - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Bionano Genomics, Inc. BNGO|APDN: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati bluebird bio Inc. BLUE|Uzoq muddatli qarzning o'z kapitaliga nisbati ImmunoPrecise Antibodies Ltd|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi OMGA (Omega Therapeutics Corp)|Uzoq muddatli qarzning kapitalga nisbati OMIC|regulusrx.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning o'z kapitaliga nisbati Syros Pharmaceuticals, Inc. SYRS|TBIO: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|TRACON - Uzoq muddatli qarzning kapitalga nisbati|UBX - Uzoq muddatli qarzning kapitalga nisbati